SEC Form 4 · accession 0001567619-18-008313
RESMED INC · RMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert Andrew Douglas
Officer — President and COO ResMed Inc.
Period of report
Dec 17, 2018
Accepted (ET)
Dec 18, 2018 · 7:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000943819
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock | Dec 17, 2018 | M | 3,307 | $43.63 | A | 89,605 | D | |
| ResMed Common Stock | Dec 17, 2018 | S | 3,307 | $112.56 | D | 86,298 | D | |
| ResMed Common Stock | Dec 17, 2018 | S | 886 | $112.56 | D | 108,336 | I | Douglas Family Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock OptionsF2 | $43.63 | Dec 17, 2018 | M | 3,307 | D | Mar 1, 2014 | Mar 1, 2020 | ResMed Commmon Stock | 3,307 | 33,065 | D |
Explanation of responses
- F1The transaction was conducted under a Rule 10b5-1 plan.
- F2Represents date options first became exercisable. Options vest 1/3 per year.